NCT06943560 Emotion Regulation Selection Flexibility Training for PTSD Patients
| NCT ID | NCT06943560 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tel Aviv University |
| Condition | PTSD |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2022-10-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical study will examine the efficacy of a novel intervention aimed at improving Regulatory Selection Flexibility and PTSD symptoms among adult individuals with PTSD symptoms, compared to a tight active control group.
Eligibility Criteria
Inclusion Criteria: * native Hebrew speakers * age between 18 - 65 * normal or corrected to normal vision * computer and internet access * fulfill screening criteria of DSM-V for PTSD Exclusion Criteria: * Complex PTSD * Psychotic disorders * substance dependence or abuse other than nicotine * Neurological condition * suicidal ideation or attempt * change in psychotherapy or pharmacological treatment in the past 3 months. * Diagnosed/suspected personality Disorder * Cognitive impairments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06943560 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943560 currently recruiting?
Yes, NCT06943560 is actively recruiting participants. Contact the research team at gsheppes@gmail.com for enrollment information.
Where is the NCT06943560 trial being conducted?
This trial is being conducted at Tel Aviv, Israel.
Who is sponsoring the NCT06943560 clinical trial?
NCT06943560 is sponsored by Tel Aviv University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.